Re: (Question) Why did Alliance put out a PR release without mentioning PTSC Wol

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

CenturyCom

Rank: Vice President [?]

Points: 7627 [?]

Votes: 100 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: (Question) Why did Alliance put out a PR release without mentioning PTSC Wol

in response to

(Question) Why did Alliance put out a PR release without mentioning PTSC

wolfpackvolt

posted on Oct 07, 2009 02:13AM

I tried sending an email to alliance licensing at the following address: mmp-licensing@alliacense.com.

Which was copied from the alliance web-site: (note bold at end)

About the MMP Portfolio™
The MMP Portfolio patents, filed by The TPL Group in the 1980s, include seven US patents as well as their European and Japanese counterparts, cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.

The MMP Portfolio™ is widely recognized as fundamental technology. The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end-user products from around the globe to become MMP Portfolio licensees. Over 65 global companies from the US, Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio technologies. Manufacturers can learn more about how to participate in the MMP Portfolio™ Licensing Program by contacting: mmp-licensing@alliacense.com